The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network
In conclusion, in NTDT patients, DFO therapy showed no advantage in terms of cardiac iron but its administration allowed an improvement in right ventricular function. Moreover, DFO reduced hepatic iron in patients with signifi cant iron burden at baseline.
Source: Annals of Hematology - Category: Hematology Source Type: research
More News: Cardiology | Heart | Hematology | Iron | Liver | MRI Scan | PET Scan | Urology & Nephrology